Lab901 has raised £3.5m in funding, which will go towards expanding its sales efforts and new products for RNA and Protein Electrophoresis – a market that is currently worth $1.3bn worldwide and expected to increase to over $1.6bn.
The money raised from this latest equity funding round is expected to build on the company’s D800 ScreenTape, a system designed for DNA analysis that is the first product from a pipeline of consumables that will be run on the company’s TapeStation instrument.¹
¹Lab Technologist, LabTechnologist.com
